BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 19217060)

  • 1. Diagnostic accuracy of flow cytometry in detecting malignant epithelial cells in serous effusions.
    Gaur G; Awasthi NP; Gupta A; Agarwal A; Sachan R; Malhotra KP; Shukla S; Singh AK; Singh P; Husain N
    J Am Soc Cytopathol; 2023; 12(6):423-435. PubMed ID: 37839931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometry in the detection of circulating tumor cells in neoplastic effusions.
    Gostomczyk K; Łukaszewska E; Borowczak J; Bator A; Zdrenka M; Bodnar M; Szylberg Ł
    Clin Chim Acta; 2024 Jan; 552():117651. PubMed ID: 37980974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Flow cytometry increases the proportion of valuable samples in cerebrospinal fluid with normal cell count in malignant blood diseases].
    Jara C; Veas C; Delgado C; Cabezas C; Chandía M
    Rev Med Chil; 2023 May; 151(5):560-564. PubMed ID: 38687537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry immunophenotyping evaluation in acute lymphoblastic leukemia: correlation to factors affecting clinic outcome.
    Alves GV; Fernandes AL; Freire JM; Paiva Ade S; Vasconcelos RC; Sales VS; Lemos TM; Gil EA; Freire FH; Cavalcanti e Silva DG; Maciel JF; Farkatt IG; Cavalcanti Júnior GB
    J Clin Lab Anal; 2012 Nov; 26(6):431-40. PubMed ID: 23143625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Cell Phenotyping Using Flow Cytometry.
    Pockley AG; Foulds GA; Oughton JA; Kerkvliet NI; Multhoff G
    Curr Protoc Toxicol; 2015 Nov; 66():18.8.1-18.8.34. PubMed ID: 26523471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of apoptosis by TUNEL assay.
    Kyrylkova K; Kyryachenko S; Leid M; Kioussi C
    Methods Mol Biol; 2012; 887():41-7. PubMed ID: 22566045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicolor flow cytometry on pericardial effusion for a prompt diagnosis and treatment of hematological malignancies with heart involvement.
    Cappannoli L; Imazio M; Hohaus S; Saponara G; D'Amario D; Bellesi S; Maiolo E; Viscovo M; Fatone F; Alma E; D'Alò F; Crea F; Sanna T
    Front Cardiovasc Med; 2022; 9():1000259. PubMed ID: 36419498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of E-cadherin and fibronectin in differentiation between reactive mesothelial and adenocarcinoma cells in serous effusions.
    Moghaddam NA; Tahririan R; Eftekhari M; Tahririan D; Rahmani A
    Adv Biomed Res; 2012; 1():56. PubMed ID: 23326787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative index using Ki-67 index in reactive mesothelial versus metastatic adenocarcinoma cells in serous fluid.
    Moghaddam NA; Rahmani A; Taheri D; Desfuli MM
    Adv Biomed Res; 2012; 1():29. PubMed ID: 23210088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric immunophenotyping of cancer cells in effusion specimens: diagnostic and research applications.
    Davidson B; Dong HP; Holth A; Berner A; Risberg B
    Diagn Cytopathol; 2007 Sep; 35(9):568-78. PubMed ID: 17703449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of flow cytometric immunophenotyping and DNA analysis for detection of malignant cells in serosal cavity fluids.
    Sayed DM; el-Attar MM; Hussein AA
    Diagn Cytopathol; 2009 Jul; 37(7):498-504. PubMed ID: 19217060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image analysis and flow cytometric DNA studies of benign and malignant body cavity fluids: reappraisal of the role of current methods in the differential diagnosis of reactive versus malignant conditions.
    Lazcano O; Chen LM; Tsai C; Li CY; Katzmann JA; Sebo TJ; Kimlinger TK; Baker J
    Mod Pathol; 2000 Jul; 13(7):788-96. PubMed ID: 10912939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT; Gentile P; Tarectecan A; Fuchs A
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions.
    Kentrou NA; Tsagarakis NJ; Tzanetou K; Damala M; Papadimitriou KA; Skoumi D; Stratigaki A; Anagnostopoulos NI; Malamou-Lada E; Athanassiadou P; Paterakis G
    Cytometry B Clin Cytom; 2011 Sep; 80(5):324-34. PubMed ID: 21695775
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.